Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Hoffmann

Vascular & Interventional Radiology Philadelphia, PA Medical Doctor

NPI 1235365974 CMS profile 147363

3624 Market St, Suite 560W, Philadelphia, PA 19104

Open in the dashboard

General payments

$240,764

163 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Hoffmann of Philadelphia, PA is reported in the CMS Open Payments database as having received $240,764 across 163 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $105,722 52
2024 General $50,867 23
2023 General $17,338 20
2022 General $19,536 29
2021 General $16,151 20
2020 General $4,929 6
2019 General $26,220 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Hoffmann
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Jason Hoffmann were reported at $105,722. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Jason Hoffmann Vascular & Interventional Radiology median Middle half National median
2019 $26,220 $422 $125–$1,555 $163
2020 $4,929 $200 $68–$652 $114
2021 $16,151 $280 $99–$866 $132
2022 $19,536 $433 $137–$1,497 $149
2023 $17,338 $506 $152–$2,019 $160
2024 $50,867 $556 $175–$1,930 $164
2025 $105,722 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merit Medical Systems Inc $198,092 87 payments
  2. Siemens Medical Solutions USA, Inc. $32,858 30 payments
  3. Varian Medical Systems, Inc. $5,711 7 payments
  4. Inari Medical, Inc. $1,554 9 payments
  5. Boston Scientific Corporation $734 7 payments
  6. Terumo Medical Corporation $475 2 payments
  7. Sirtex Medical Inc $439 5 payments
  8. Medtronic, Inc. $373 5 payments
  9. Penumbra, Inc. $295 5 payments
  10. Balt USA, LLC $107 1 payment
  11. Other $124 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $156,484 61 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $71,328 11 payments
  3. Travel and Lodging $8,000 26 payments
  4. Food and Beverage $4,952 65 payments
Products named General payments · program years 2019–2025
  1. Embosphere Microspheres $15,276 15 payments
  2. SwiftNINJA Sterble Cor Micro $11,503 13 payments
  3. Wrapsody Stent Graft $11,029 6 payments
  4. Microsphere Embospheres $7,929 9 payments
  5. Merit Meastro Microcatheters $6,413 1 payment
  6. Quadrasphere Microspheres Radiology $3,500 1 payment
  7. Embozene $3,300 8 payments
  8. QuadraSphere Microspheres Vascular $1,580 1 payment
  9. CT THROMBECTOMY SYSTEM KIT $1,554 9 payments
  10. FLOWTRIEVER CATHETER, S $1,554 9 payments
  11. Other $4,697 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

37

Median for Diagnostic Radiology: 24

Drug cost

$96

Median for Diagnostic Radiology: $190

Branded share of claims

54.1%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 20 $58
Ibuprofen Generic 17 $38

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$93,886

Medicare's payments for the services billed

Medicare patients

447

Average age 77

Services billed

1,220

174 women, 273 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 63%
Arthritis 60%
Chronic kidney disease 58%
Diabetes 48%
Heart failure 45%
Atrial fibrillation 40%
Cancer 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

163 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record